Future studies should aim to correlate specific bacterial taxa with clinical outcomes in human cohorts
Built by 15+ years of ISSCA clinical education
Monitoring During Treatment: Continuous monitoring by our trained medical staff during IV or IM administration ensures any adverse reactions are promptly addressed, and patient comfort is maintained
The experiment was divided into a normal control group, a radiotherapy model group, and a radiotherapy+IGF-1 LR3 treatment group (1mg/kg, orally taken from the first day after radiotherapy, once a day, for 7 consecutive days)
In the parent study, 24 weeks of low-dose semaglutide (1 mg subcutaneously weekly) significantly reduced IHTG by 31.3%, improved insulin sensitivity (approximately 1.5-unit decrease in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)), and lowered triglyceride levels by 27 mg/dL 12
Industry Roadmap 4